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Abstract
Objective: To provide access to the results of a randomized cross-sectional study conducted by the Brazilian Center 
for Information on Psychotropic Drugs in 2001. Methods: This survey involved a random sample of individuals 
ranging from 12 to 65 years of age and residing in the 107 largest cities (over 200,000 inhabitants) in Brazil, which 
represented 27.7% of the Brazilian population, estimated to be 169,799,170 inhabitants at the time. A total of 
8,589 interviews were conducted. The Substance Abuse and Mental Health Services Administration questionnaire, 
translated and adapted for use in Brazil, was used in the interviews. Results: Of the sample as a whole, 41.1% of 
the interviewees reported having experimented with tobacco products. The prevalence of daily smokers was 17.4% 
(20.3% among males and 14.8% among females). We found that 9% of the sample (10.1% of the men and 7.9% 
of the women) were nicotine-dependent, according to the criteria of the National Household Survey on Drug 
Abuse. Conclusions: The prevalence of current smoking in the 107 largest cities of Brazil is significantly lower in 
this decade than was the national prevalence at the end of last century. 
Keywords: Smoking/epidemiology; Tobacco use disorder; Smoking cessation.
Resumo
Objetivo: Divulgar os dados de um estudo transversal randomizado, realizado em 2001, pelo Centro Brasileiro de 
Informações sobre Drogas Psicotrópicas. Métodos: A população pesquisada neste levantamento incluiu indivíduos 
com 12-65 anos de idade, residentes nos 107 maiores municípios do Brasil (com mais de 200 mil habitantes), o 
que representou 27,7% da população brasileira na época, estimada em 169.799.170 habitantes. Foram realizadas 
no total 8.589 entrevistas. Utilizou-se o questionário Substance Abuse and Mental Health Services Administration, 
que foi traduzido e adaptado para o uso no Brasil. Resultados: Do total, 41,1% dos entrevistados disseram já ter 
utilizado produtos derivados de tabaco alguma vez na vida. A prevalência de uso diário de tabaco foi de 17,4% 
da amostra (20,3% entre os homens e 14,8% entre as mulheres). Observou-se que 9% da população (10,1% entre 
os homens e 7,9% entre as mulheres) são dependentes da nicotina, segundo os critérios do National Household 
Surveys on Drug Abuse. Conclusões: A prevalência do uso diário de tabaco, nos maiores municípios brasileiros, é 
significativamente menor na presente década do que a prevalência nacional ao final do século passado. 
Descritores: Tabagismo/epidemiologia; Transtorno por uso de tabaco; Abandono do hábito de fumar.
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on Psychotropic Drugs – São Paulo, Brazil.
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Introduction
According to the World Health Organization, 
smoking is the principal preventable cause of 
death and disease worldwide, affecting more 
than one billion people. Smoking accounts for 
more than 5 million deaths per year worldwide, 
and it is estimated that smoking will account 
for more than 10 million deaths per year in 
2030. It is believed that, in Brazil, approximately 
200,000 deaths per year occur as a result of 
smoking.(1,2)
The Brazilian National Survey on Health and 
Nutrition, conducted in 1989, provided impor-
tant data regarding the epidemiology of tobacco 
consumption in the Brazilian population. 
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total number of households in the sector under 
study divided by 24. For instance, there were 
260 houses in sector 25 of the city of São Paulo 
(Capão Redondo neighborhood). Therefore, the 
interval of selection for that sector would be 
10.83 (260 ÷ 24), which was rounded up to 11. 
Still using the Capão Redondo neighborhood 
as an example, the interviewer in charge chose 
any of the households in the sector as the first 
household and then, based on the interval of 
selection, counted 11 households in order to 
identify the second household, and so on. The 
interviewers were instructed not to consider 
commercial establishments, hospitals, factories, 
boarding houses or hotels. In the case of residen-
tial buildings, each apartment was considered a 
household. Therefore, more than one interview 
might take place in the same building.
For each household selected, all residents 
were identified and registered in decreasing 
order by age, first the men and then the women. 
Subsequently, tables were used for random 
drawing, as defined by Kish.(7) The tables had a 
fixed sequence of numbers on the upper line, in 
order to register the number of residents in the 
household, and a random number on the lower 
line, which was used to determine who would be 
interviewed, according to the order in which the 
residents were registered. In certain situations 
(after three unsuccessful attempts at obtaining 
an interview; if any given person refused, 
partially or completely, to be interviewed; 
impediment on the part of the family—physical 
or mental impairment; and impossibility of 
carrying out the interview due to travel or hospi-
talization), the interviewers were instructed to 
select a substitute, provided that the substitute 
lived in the same census sector and was of the 
same gender, belonged to the same age bracket 
and had the same socioeconomic profile of the 
person that had been initially chosen through 
random drawing.
We employed the Substance Abuse and 
Mental Health Services Administration (SAMHSA) 
questionnaire, developed by the U.S. Department 
of Health and Human Services,(8) which has been 
translated and adapted for use in Brazil. The 
first part of the questionnaire contains explana-
tions regarding the survey; the second part is 
used in order to register the demographic data 
of the interviewee (gender, age, skin color and 
socioeconomic level); the third and fourth parts 
According to that study, the total prevalence 
of smoking in Brazil reached the impressive 
rate of 34.8%, corresponding to approximately 
30.6 million current smokers over 15 years of 
age, of whom 18.2 million (43.3%) were male 
and 12.4 million (27.0%) were female.(3,4)
The First House-to-House Survey on 
Psychotropic Drug Use provided important 
and recent information regarding the preva-
lence of smoking in the Brazilian population, 
the percentage of nicotine-dependent indi-
viduals and the components of nicotine 
dependence. That was a randomized nation-
wide study that involved different age brackets 
and was conducted by the Brazilian Center for 
Information on Psychotropic Drugs in 2001.(5) 
The present article refers to the data regarding 
tobacco consumption in Brazil collected during 
that survey.
Methods
The present survey was conducted between 
September and December of 2001, and the 
target population comprised individuals in the 
12-65 age bracket who resided in the largest 
cities of Brazil. The sample included all cities 
with over 200,000 inhabitants according to 
data from the census conducted in 1995 by the 
Instituto Brasileiro de Geografia e Estatística 
(IBGE, Brazilian Institute of Geography and 
Statistics).(6) A total of 107 cities, which repre-
sented 27.7% of the Brazilian population 
(estimated to be 169,799,170 at the time), were 
studied. Tocantins was the only state that was 
not included in the study, because none of its 
cities has more than 200,000 inhabitants.
Each city under study was divided into 
census sectors (comprising 200-300 households) 
because, according to the IBGE, a census sector 
is the smallest unit that provides socioeconomic 
information. Subsequently, groups of homoge-
neous sectors, designated “strata”, were created 
using multivariate statistical techniques. The 
number of households to be surveyed in each 
census sector was set at 24, which was consid-
ered ideal for the purpose of the study and, at 
the same time, within the budget.
In each census sector, the households were 
selected systematically, the first household being 
chosen randomly. In order to ensure the random-
ness of the sample, an interval of selection was 
created for each sector, corresponding to the 
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•	Having	developed	a	tolerance	to	the	drug	
in question (greater quantity required in 
order to produce the same effects)
•	Engaging	in	physically	risky	behavior	(e.g.,	
driving, piloting, operating machinery, 
swimming, etc.) while under the influence 
of the drug in question or soon after its 
effects have waned 
•	Having	personal	 problems	 (e.g.,	 problems	
with family, friends or the police; problems 
at work; or emotional problems) due to the 
use of the drug in question
•	Wishing	to	reduce	or	eliminate	the	use	of	
due to the use of the drug in question
The NHSDA criteria (found in the SAMHSA 
questionnaire) and their reliability were previ-
ously validated in a study conducted in the state 
of São Paulo in 1999, thus allowing their use in 
the present study.(11)
Results
The population investigated in the present 
survey included individuals in the 12- to 65-year 
age bracket residing in the 107 largest cities of 
Brazil (cities with more than 200,000 inhabitants), 
which corresponded to 47,045,907 inhabit-
ants (27.7% of the Brazilian population at the 
time; Table 1). A total of 9,480 households were 
randomly selected, and a total of 8,589 inter-
views were conducted, the rate of failure being 
9.3%. Regarding the distribution according to 
gender, the Brazilian population at the time 
was composed of 49% men and 51% women, 
whereas the study sample was composed of 43% 
men and 57% women.
Of the sample as a whole, 49.0% were 
≥ 35 years of age; 18.0% were in the 25-34 age 
bracket; 21.0% were in the 18-24 age bracket; 
and 12.0% were in the 12-17 age bracket. 
address the use of psychotropic drugs, including 
nicotine, and aim to gather detailed information 
regarding lifetime use and frequency of use; the 
fifth part, which does not apply to the present 
article, is used in order to evaluate injection drug 
use; the sixth part includes the criteria for drug 
dependence, in accordance with the Diagnostic 
and Statistical Manual of Mental Disorders, 
Third Edition, Revised (DSM-III-R)(9); the seventh 
part is used in order to determine whether inter-
viewees have sought treatment for dependence; 
and the eighth part is used in order to determine 
whether interviewees have experienced compli-
cations related to drug use.
The socioeconomic status of the interviewee 
(second part of the SAHMSA questionnaire) was 
determined in accordance with the classification 
proposed by the Brazilian Association of the 
Market Research Institutes,(10) which takes into 
consideration the level of education and items 
owned by the interviewee, such as the number of 
automobiles, radios, refrigerators, etc. According 
to this classification, the interviewee is catego-
rized using a system of letters, from A to E, in 
which A indicates the highest socioeconomic 
level and E indicates the lowest.
Psychoactive drug dependence was diag-
nosed in accordance with the criteria of the 
National Household Surveys on Drug Abuse 
(NHSDA), which uses six of the nine criteria 
found in the DSM-III-R.(9) Patients were iden-
tified as being dependent on any given drug, 
including nicotine, if they met at least two of 
the following criteria:
•	Spending	 a	 considerable	 amount	 of	 time	
obtaining, using or recovering from the 
effects of the drug in question
•	Using	 the	 drug	 in	 question	 in	 greater	
quantities or frequency than intended
Table 1 - Population represented in the sample, percentage evaluated per region, number of census sectors 
surveyed and lifetime tobacco use, in Brazil and in each of the five regions of Brazil, in 2001.
Region of 
Brazil
Cities with 
over 200,000 
inhabitants, n
Population 
represented, n
% of the 
total
Sectors 
investigated, n
Lifetime tobacco use 
% (95% CI)
North 8 2,948,749 22.8 26 33.8 (21.0-46.7)
Northeast 22 9,108,348 19.1 78 37.4 (29.5-45.3)
Central-West 7 3,634,977 31.2 29 34.0 (22.2-45.8)
South 18 4,425,486 17.6 43 44.1 (32.4-55.7)
Southeast 52 26,928,350 37.1 219 43.6 (38.6-48.6)
Total 107 47,045,907 27.7 395 41.1 (37.5-44.7)
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previous month were quite similar—19.5% (95% 
CI: 18.0-21.1) and 19.2% (95% CI: 18.4-21.0), 
respectively.
The prevalence of daily smoking in the 
sample was 17.4% (20.3% among the men and 
14.8% among the women; 95% CI: 15.1-19.8). 
Among those ≥ 35 years of age, the prevalence 
was higher, reaching 24.0% (28.3% among the 
men and 20.3% among the women; 95% CI: 
22.0-26.0).
Another important finding refers to the 
number of nicotine-dependent smokers, which 
was evaluated in accordance with the NHSDA 
dependence criteria. We found that 9.0% of the 
interviewees (95% CI: 7.2-10.7) met the criteria 
for nicotine dependence (10.1% of the men 
and 7.9% of the women). These data translate 
to 51.7% of the daily smokers (49.8% of the 
men and 53.4% of the women) being nicotine-
dependent. From the age of 18 onward, women 
presented prevalence rates of nicotine depend-
ence that were closer to those observed for men; 
however, the prevalence of nicotine dependence 
among women was never greater than was that 
among men, in any age bracket.
The proportion of women and of individuals 
≥ 35 years of age was higher in the sample than 
in the Brazilian population at large (57.0% and 
49.0% vs. 51.0% and 41.0%). In contrast, only 
12.0% of the interviewees were in the 12-17 age 
bracket, compared with 18.0% of the Brazilian 
population as a whole.
Regarding the socioeconomic status, the 
distribution of the interviewees into the classes 
was as follows: class A, 6%; class B, 19%; class C, 
36%; class D, 29%; and class E, 10%. This 
demonstrates that the majority of the sample 
was composed of individuals in the low-income 
brackets, classes C and D predominating.
Of all the interviewees, 41.1% (95% CI: 
37.5-44.7) had experimented with tobacco at 
least once, the percentage being higher among 
men than among women (46.2%; 95% CI: 
42.3-50.0 vs. 36.3%; 95% CI: 33.2-39.4, respec-
tively). Table 1 shows the percentages of lifetime 
tobacco use in each of the five regions of Brazil, 
and Table 2 shows the percentages of lifetime 
tobacco use according to the gender of the inter-
viewees in the country and the age bracket to 
which they belonged. The rates for tobacco use 
in the previous year and for tobacco use in the 
Table 2 - Daily tobacco use and lifetime tobacco use, distributed according to the gender of the interviewees 
and the age bracket to which they belonged, in the 107 largest Brazilian cities (with over 200,000 inhabitants) 
in 2001.
Age 
bracket, 
years
Total 
and by 
gender
Daily use Lifetime use
Observed, % Estimated 
population,a
n × 1,000
95% CI Observed, 
%
Estimated 
population,a
n × 1,000
95% CI
12-17 Total
M
F
3.7
4.5
3.0
280
165
116
(2.1-5.4)
(2.7-6.3)
(1.5-4.5)
15.7
15.2
16.2
1,177
560
618
(12.4-19.0)
(12.1-18.3)
(12.9-19.4)
18 to 24 Total
M
F
16.0
19.2
12.7
1,475
885
590
(13.2-18.7)
(16.3-22.2)
(10.5-15.0)
37.7
42.8
32.6
3,482
1,974
1,508
(33.8-41.6)
(39.1-46.5)
(29.5-35.7)
25 to 34 Total
M
F
16.3
18.3
14.3
1,735
972
763
(13.7-18.8)
(15.7-21.0)
(12.1-16.4)
40.0
43.9
36.1
4,261
2,329
1,932
(36.3-43.7)
(40.5-47.3)
(33.2-39.1)
> 35 Total
M
F
24.0
28.3
20.2
4,718
2,610
2,109
(22.0-26.0)
(26.1-30.4)
(18.7-21.8)
53.0
61.4
45.4
10,408
5,674
4,734
(50.5-55.7)
(59.1-63.7)
(43.5-47.4)
All age 
brackets
Total
M
F
17.4
20.3
14.8
8,208
4,632
3,577
(15.1-19.8)
(17.7-22.9)
(12.8-16.7)
41.1
46.2
36.3
19,328
10,537
8,791
(37.5-44.7)
(42.3-50.0)
(33.2-39.4)
aIn some cases, the sum of the thousands between men and women does not add up because the data are the results of 
formulas applied separately. The estimates were obtained through weighting by age and by gender.
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country were current smokers (20.3% of the 
men and 14.8% of the women); the prevalence 
increased to 24.0% when only those ≥ 35 years 
or age were considered (28.3% of the men and 
20.2% of the women). Although the study did 
not include all of the cities in Brazil, which 
would have been practically impossible, it has 
the merit of having evaluated all Brazilian cities 
with over 200,000 inhabitants, in all regions 
of the country and in a randomized manner, 
which should reflect the general attitude of the 
Brazilian population toward smoking.
The prevalence of smoking found in the 
present study is corroborated by findings of 
recent studies, which have also found a lower 
prevalence of smoking than that found in studies 
conducted in previous decades.(3,12,13) It is possible 
that the overall consumption of tobacco among 
the Brazilian population stabilized between 
2001 and 2004, since a randomized study 
conducted in 2003 and involving the population 
over 40 years of age in the metropolitan area of 
São Paulo reported the prevalence of smoking 
to be 24.0%, exactly the same at that observed 
for individuals ≥ 35 years of age in the present 
study.(12) The World Health Survey, developed by 
the World Health Organization, was a world-
wide investigation into the health conditions in 
various countries. The data from the implemen-
tation of the World Health Survey in Brazil (in 
2003) also seem to indicate stabilization, since 
the application of questionnaires to 5,000 indi-
viduals ≥ 18 years of age revealed the prevalence 
of current smoking in the Brazilian population 
to be 22.4%.(13) Finally, in 2008, the prevalence 
Table 3 provides further information 
regarding the signs and symptoms that consti-
tute nicotine dependence, specifically in the 
previous year of use. The highest proportion 
of affirmative answers was observed among 
individuals ≥ 35 years of age. In contrast, the 
lowest proportion of affirmative answers on the 
questionnaire was observed among interviewees 
in the 12-17 age bracket. Another interesting 
finding was related to the question regarding 
the desire to reduce or quit smoking, which only 
16.4% of the interviewees (95% CI: 14.1-18.7)—
19% of the men (95% CI: 22.3-26.4) and 14% 
of the women (95% CI: 16.1-19.1)—answered 
affirmatively. Nevertheless, that was the ques-
tion for which the proportion of affirmative 
responses was the highest, ranging from 20.8% 
among the interviewees ≥ 35 years of age 
(95% CI: 18.9-22.7) to 5.3% among those in 
the 12-17 age bracket (95% CI: 3.3-7.3). The 
question for which the proportion of affirma-
tive responses was the second highest was that 
regarding loss of control, which is characterized 
by the consumption of a higher than intended 
number of cigarettes and was reported by 8.2% 
of the interviewees.
Discussion
The present study was carried out 12 years 
after the Brazilian National Survey on Health 
and Nutrition (1989) and aided in revealing the 
behavior of the Brazilian population regarding 
tobacco consumption. According to the data 
obtained for 2001, 17.4% of the Brazilian popu-
lation residing in the 107 largest cities of the 
Table 3 - Answers to questions on the Substance Abuse and Mental Health Services Administration questionnaire 
regarding the different components of nicotine dependence (signs/symptoms) in the previous year in the 
107 Brazilian cities with over 200,000 inhabitants in 2001.
Attributes of smoking in the previous year Age bracket, years
12-17 18-25 26-34 ≥ 35 Total
% % % % %
Significant amounts of time losta 0.2 2.3 2.7 3.9 2.7
Greater frequencyb 1.5 7.3 9.2 10.7 8.2
Tolerancec 0.1 1.3 1.6 1.3 1.2
Physical risksd * * * * *
Personal problemse 2.1 4.2 3.6 4.6 3.9
Wanted to quit or reduce smoking 5.3 15.7 16.8 20.8 16.4
aIn obtaining, using or recovering from the effects of nicotine. bSmoked more or more often than intended. cGreater quan-
tity required in order to produce the same effects. dEngaged in physically risky behavior (driving, piloting, using machines, 
etc.) while under the influence of nicotine or soon after its effects have waned. eSmoking-related problems: with family or 
friends; at work; emotional disorders; or psychological difficulties. *Low precision.
Random sample survey on the prevalence of smoking in the major cities of Brazil
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13-15 age bracket) were interviewed. Lifetime 
tobacco use among students decreased from 
33.7% in 1997 to 21.8% in 2004.
In addition to the reduction in the prevalence 
of smoking in Brazil between the end of the 
20th century and the beginning of the current 
century, according to recent studies (including 
the present one), there was a decrease in the 
annual per capita consumption of cigarettes in 
the same period: a decrease of approximately 
30% between 1989 and 2002, even computing 
the estimates of consumption of contraband 
and counterfeit cigarettes,(3) mean cigarette 
consumption having decreased from 14.9/day in 
1989 to 12.6/day in 2003.(13)
Approximately 30.0% of Brazilian smokers 
smoke 20 or more cigarettes per day, which 
suggests a high level of dependence.(20) This 
is in accordance with the results of a recently 
published study, in which the mean Fagerström 
test score(21) was high (6.2 ± 2.0) among 
203 smokers who sought a smoking cessation 
program.(22) This finding shows the importance 
of determining not only the number of smokers 
but also the prevalence of nicotine depend-
ence in the population. This is justified by the 
fact that the treatment of nicotine-dependent 
smokers should have a broader approach and 
include pharmacological intervention.(23) In this 
context, the present study is, to date, the only 
study that has provided data regarding the 
prevalence of nicotine dependence in a large 
population sample, as well as the prevalence of 
the principal signs and symptoms of nicotine 
dependence. Our survey showed that, according 
the NHSDA criteria, 9.0% of the sample (10.1% 
of the men and 7.9% of the women), and 
probably of the Brazilian population, are nico-
tine-dependent. The questions receiving the 
greatest numbers of affirmative responses were 
those regarding excessive consumption and the 
desire to reduce or quit smoking. The highest 
prevalence of nicotine dependence was observed 
among individuals ≥ 35 years of age (11.3%), 
which is explained by the longer smoking history, 
which increases smoking exposure and, conse-
quently, the probability of becoming dependent. 
The lowest prevalence of nicotine dependence 
was found among the youngest individuals 
(12-17 age bracket), many of whom were prob-
ably still in the experimentation phase. It should 
of smoking among the 2,488 residents over 
19 years of age of a small city in Rio Grande 
do Norte was reported to be 23.5%, and there 
were no differences between the urban and rural 
areas.(14)
According to the stages of the model 
proposed by Lopez et al.(15) to describe the evolu-
tion of the behavior of the smoking epidemic 
(and based on the data from the present study 
and on those from other studies), Brazil is prob-
ably in transition between stages III and IV.(12,13) 
At stage III, the prevalence of smoking among 
men stabilizes and begins to drop rapidly, espe-
cially among those who are younger and have a 
higher level of education; women reach the peak 
of prevalence at stage III and, at the end of the 
stage, that prevalence begins to drop. At stage 
IV, the prevalence continues to drop among men 
and women, and smoking increasingly becomes 
a behavior of less privileged socioeconomic 
groups. It is interesting to observe the difference 
in the behavior of the prevalence of smoking 
among both genders by comparing the data 
from the Brazilian National Survey on Health and 
Nutrition, conducted in 1989 (Brazilian popula-
tion sample: prevalence of 43.3% among men 
and of 27.0% among women), with those from 
the present study, conducted in 2001 (popula-
tion sample of the 107 largest Brazilian cities: 
prevalence of 20.3% among men and of 14.8% 
among women).(3,5) The evaluation of these data 
shows that, among both genders, the prevalence 
of current smoking is decreasing; however, men 
are quitting smoking more rapidly, which is in 
accordance with the model proposed by Lopez 
et al.(15)
Our data show that, within the study sample, 
15.7% of the interviewees in the 12-17 age 
bracket had experimented with smoking. In a 
recent study involving young college students 
from Brasília (mean age: 21.6 ± 3.6 years), the 
prevalence of smoking was 17.4% (quite close to 
the prevalence found in the present study).(16) 
Among the various factors favoring smoking 
experimentation by young Brazilians are the low 
price of cigarettes in Brazil—one of the lowest in 
the world—and the ease of access to cigarettes in 
the country.(17,18) Despite this, cigarette use in this 
age bracket has decreased considerably in recent 
years, as was well documented in a nationwide 
survey on psychotropic drug consumption,(19) 
in which 1,558 students (predominantly in the 
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